Ipopema Securities SA
WSE:IPE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.36
4.06
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ipopema Securities SA
Cash & Cash Equivalents
Ipopema Securities SA
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Ipopema Securities SA
WSE:IPE
|
Cash & Cash Equivalents
zł187.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
|
X
|
Xtb SA
WSE:XTB
|
Cash & Cash Equivalents
zł4.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
S
|
Skyline Investment SA
WSE:SKL
|
Cash & Cash Equivalents
zł143k
|
CAGR 3-Years
128%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
L
|
Letus Capital SA
WSE:LET
|
Cash & Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Reino Capital SA
WSE:RNC
|
Cash & Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Novavis Group SA
WSE:NVG
|
Cash & Cash Equivalents
zł3m
|
CAGR 3-Years
146%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Ipopema Securities SA
Glance View
IPOPEMA Securities SA engages in the provision of brokerage services. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 254 full-time employees. The company went IPO on 2009-05-26. The firm specializes in investment banking services such as preparation and execution of transactions on the capital market using share instruments, debentures and hybrid instruments. Ipopema Securities SA also provides brokerage services as well as company analyses. The Company’s offer is above all addressed to domestic and foreign corporate customers and also includes the access to developed foreign stock markets as well as emerging markets. As of December 31, 2011, the Company operated three subsidiaries, wholly owned Ipopema Towarzystwo Funduszy Inwestycyjnych SA and Ipopema Asset Management, as well as 50.02%-owned Ipopema Business Consulting Sp. z o.o.
See Also
What is Ipopema Securities SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
187.1m
PLN
Based on the financial report for Sep 30, 2024, Ipopema Securities SA's Cash & Cash Equivalents amounts to 187.1m PLN.
What is Ipopema Securities SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
17%
Over the last year, the Cash & Cash Equivalents growth was 8%. The average annual Cash & Cash Equivalents growth rates for Ipopema Securities SA have been 3% over the past three years , 28% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
